SA

Swati Agrawal

Active Director Director DIN 09105357
DIN 09105357 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Swati Agrawal

Data last updated:

Swati Agrawal is a Director at Havex Remedies Private Limited (since 2021). The company operates in Chemicals. Havex Remedies Private Limited reported revenue of ₹78.1 Lakh (FY 2024).

DIN 09105357
Primary Designation Director
Industry Chemicals
First Appointment 13 Mar 2021
Oldest Company Age 5 yrs
Largest company Havex Remedies Private Limited · ₹78.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Havex Remedies Private Limited U24230UP2021PTC143437
Director13 Mar 20212021₹78.1 Lakh (FY 2024)Active

Board colleagues of Swati Agrawal

NameDINCompanyDesignation
Lovely Agrawal09105356Havex Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Havex Remedies Private Limited
Premium access

Shareholding and investment profile for Swati Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Agrawal

Swati Agrawal currently holds 1 directorship: Havex Remedies Private Limited (Director, since 13 Mar 2021, revenue ₹78.1 Lakh (FY 2024)).

Swati Agrawal was first appointed on 13 Mar 2021 as Director at Havex Remedies Private Limited.

The current boards of Swati Agrawal's companies include Lovely Agrawal (Havex Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available